Redmile Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-913,319
Closed -$72.8M 78
2022
Q2
$72.8M Buy
+913,319
New +$72.8M 2.78% 7
2019
Q4
Sell
-14,700
Closed -$400K 87
2019
Q3
$400K Buy
14,700
+3,300
+29% +$89.8K 0.01% 60
2019
Q2
$274K Buy
+11,400
New +$274K 0.01% 72
2018
Q3
Sell
-25,800
Closed -$427K 101
2018
Q2
$427K Buy
25,800
+5,800
+29% +$96K 0.01% 69
2018
Q1
$284K Hold
20,000
0.01% 61
2017
Q4
$292K Buy
+20,000
New +$292K 0.01% 63